Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3589462
Max Phase: Preclinical
Molecular Formula: C31H28N4O9
Molecular Weight: 600.58
Molecule Type: Small molecule
Associated Items:
ID: ALA3589462
Max Phase: Preclinical
Molecular Formula: C31H28N4O9
Molecular Weight: 600.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3nnnc3C(=O)OCc3ccccc3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC
Standard InChI: InChI=1S/C31H28N4O9/c1-38-23-9-17(10-24(39-2)28(23)40-3)25-18-11-21-22(44-15-43-21)12-19(18)27(20-14-42-30(36)26(20)25)35-29(32-33-34-35)31(37)41-13-16-7-5-4-6-8-16/h4-12,20,25-27H,13-15H2,1-3H3/t20-,25+,26-,27+/m0/s1
Standard InChI Key: ZFLKFBUHBALVCX-ULBKPHCJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 600.58 | Molecular Weight (Monoisotopic): 600.1856 | AlogP: 3.31 | #Rotatable Bonds: 8 |
Polar Surface Area: 142.35 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.40 | CX LogD: 3.40 |
Aromatic Rings: 4 | Heavy Atoms: 44 | QED Weighted: 0.27 | Np Likeness Score: 0.15 |
1. Hyder I, Yedlapudi D, Kalivendi SV, Khazir J, Ismail T, Nalla N, Miryala S, Sampath Kumar HM.. (2015) Synthesis and Biological evaluation of novel 4β-[(5-substituted)-1,2,3,4-tetrazolyl] podophyllotoxins as anticancer compounds., 25 (14): [PMID:26022842] [10.1016/j.bmcl.2015.04.053] |
Source(1):